{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T23:05:06Z","timestamp":1792191906890,"version":"4.4.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"name":"European Research Council","award":["281156"],"award-info":[{"award-number":["281156"]}]},{"name":"Netherlands Organization for Health Research and Development (ZonMw)","award":["016.116.358"],"award-info":[{"award-number":["016.116.358"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12974-015-0372-y","type":"journal-article","created":{"date-parts":[[2015,8,13]],"date-time":"2015-08-13T19:58:15Z","timestamp":1439495895000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Adjuvant treatment with dexamethasone plus anti-C5 antibodies improves outcome of experimental pneumococcal meningitis: a randomized controlled trial"],"prefix":"10.1186","volume":"12","author":[{"given":"E. Soemirien","family":"Kasanmoentalib","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes","family":"Valls Seron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B. Paul","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthijs C.","family":"Brouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederik","family":"van de Beek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,8,15]]},"reference":[{"key":"372_CR1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1056\/NEJMoa040845","volume":"351","author":"D Beek van de","year":"2004","unstructured":"van de Beek D, de Gans J, Spanjaard L, Weisfelt M, Reitsma JB, Vermeulen M. Clinical features and prognostic factors in adults with bacterial meningitis. N Engl J Med. 2004;351:1849\u201359.","journal-title":"N Engl J Med"},{"key":"372_CR2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1128\/CMR.00008-11","volume":"24","author":"BB Mook-Kanamori","year":"2011","unstructured":"Mook-Kanamori BB, Geldhoff M, van der Poll T, van de Beek D. Pathogenesis and pathophysiology of pneumococcal meningitis. Clin Microbiol Rev. 2011;24:557\u201391.","journal-title":"Clin Microbiol Rev"},{"key":"372_CR3","volume":"6","author":"MC Brouwer","year":"2013","unstructured":"Brouwer MC, McIntyre P, Prasad K, van de Beek D. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev. 2013;6, CD004405.","journal-title":"Cochrane Database Syst Rev"},{"key":"372_CR4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","volume":"347","author":"J Gans de","year":"2002","unstructured":"de Gans J, van de Beek D. Dexamethasone in adults with bacterial meningitis. N Engl J Med. 2002;347:1549\u201356.","journal-title":"N Engl J Med"},{"key":"372_CR5","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.1172\/JCI57522","volume":"121","author":"B Woehrl","year":"2011","unstructured":"Woehrl B, Brouwer MC, Murr C, Heckenberg SG, Baas F, Pfister HW, et al. Complement component 5 contributes to poor disease outcome in humans and mice with pneumococcal meningitis. J Clin Invest. 2011;121:3943\u201353.","journal-title":"J Clin Invest"},{"key":"372_CR6","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1128\/CMR.00070-09","volume":"23","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Tunkel AR, van de Beek D. Epidemiology, diagnosis, and antimicrobial treatment of acute bacterial meningitis. Clin Microbiol Rev. 2010;23:467\u201392.","journal-title":"Clin Microbiol Rev"},{"key":"372_CR7","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/S0140-6736(12)61186-6","volume":"380","author":"D Beek van de","year":"2012","unstructured":"van de Beek D, Brouwer MC, Thwaites GE, Tunkel AR. Advances in treatment of bacterial meningitis. Lancet. 2012;380:1693\u2013702.","journal-title":"Lancet"},{"key":"372_CR8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature11556","volume":"490","author":"SC Landis","year":"2012","unstructured":"Landis SC, Amara SG, Asadullah K, Austin CP, Blumenstein R, Bradley EW, et al. A call for transparent reporting to optimize the predictive value of preclinical research. Nature. 2012;490:187\u201391.","journal-title":"Nature"},{"key":"372_CR9","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1212\/WNL.0b013e3181f96297","volume":"75","author":"MC Brouwer","year":"2010","unstructured":"Brouwer MC, Heckenberg SG, de Gans J, Spanjaard L, Reitsma JB, van de Beek D. Nationwide implementation of adjunctive dexamethasone therapy for pneumococcal meningitis. Neurology. 2010;75:1533\u20139.","journal-title":"Neurology"},{"key":"372_CR10","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1186\/1471-2334-12-71","volume":"12","author":"B Mook-Kanamori","year":"2012","unstructured":"Mook-Kanamori B, Geldhoff M, Troost D, van der Poll T, van de Beek D. Characterization of a pneumococcal meningitis mouse model. BMC Infect Dis. 2012;12:71.","journal-title":"BMC Infect Dis"},{"key":"372_CR11","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1056\/NEJMoa1208981","volume":"368","author":"CM Legendre","year":"2013","unstructured":"Legendre CM, Licht C, Muus P, Greenbaum LA, Babu S, Bedrosian C, et al. Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome. N Engl J Med. 2013;368:2169\u201381.","journal-title":"N Engl J Med"},{"key":"372_CR12","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1001\/jama.297.17.1881-b","volume":"297","author":"PW Armstrong","year":"2007","unstructured":"Armstrong PW, Granger CB, Adams PX, Hamm C, Holmes Jr D, O\u2019Neill WW, et al. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial. JAMA. 2007;297:43\u201351.","journal-title":"JAMA"},{"key":"372_CR13","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1056\/NEJMoa061648","volume":"355","author":"P Hillmen","year":"2006","unstructured":"Hillmen P, Young NS, Schubert J, Brodsky RA, Socie G, Muus P, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233\u201343.","journal-title":"N Engl J Med"},{"key":"372_CR14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jtcvs.2010.08.035","volume":"142","author":"PK Smith","year":"2011","unstructured":"Smith PK, Shernan SK, Chen JC, Carrier M, Verrier ED, Adams PX, et al. Effects of C5 complement inhibitor pexelizumab on outcome in high-risk coronary artery bypass grafting: combined results from the PRIMO-CABG I and II trials. J Thorac Cardiovasc Surg. 2011;142:89\u201398.","journal-title":"J Thorac Cardiovasc Surg"},{"key":"372_CR15","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S1474-4422(03)00623-9","volume":"3","author":"A Chaudhuri","year":"2004","unstructured":"Chaudhuri A. Adjunctive dexamethasone treatment in acute bacterial meningitis. Lancet Neurol. 2004;3:54\u201362.","journal-title":"Lancet Neurol"},{"key":"372_CR16","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/ncpneuro0265","volume":"2","author":"D Beek van de","year":"2006","unstructured":"van de Beek D, Weisfelt M, de Gans J, Tunkel AR, Wijdicks EF. Drug insight: adjunctive therapies in adults with bacterial meningitis. Nat Clin Pract Neurol. 2006;2:504\u201316.","journal-title":"Nat Clin Pract Neurol"},{"key":"372_CR17","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S1474-4422(10)70023-5","volume":"9","author":"D Beek van de","year":"2010","unstructured":"van de Beek D, Farrar JJ, de Gans J, Mai NT, Molyneux EM, Peltola H, et al. Adjunctive dexamethasone in bacterial meningitis: a meta-analysis of individual patient data. Lancet Neurol. 2010;9:254\u201363.","journal-title":"Lancet Neurol"},{"key":"372_CR18","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1086\/425368","volume":"39","author":"AR Tunkel","year":"2004","unstructured":"Tunkel AR, Hartman BJ, Kaplan SL, Kaufman BA, Roos KL, Scheld WM, et al. Practice guidelines for the management of bacterial meningitis. Clin Infect Dis. 2004;39:1267\u201384.","journal-title":"Clin Infect Dis"},{"key":"372_CR19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/ncpneuro0713","volume":"4","author":"MT Fitch","year":"2008","unstructured":"Fitch MT, van de Beek D. Drug insight: steroids in CNS infectious diseases\u2014new indications for an old therapy. Nat Clin Pract Neurol. 2008;4:97\u2013104.","journal-title":"Nat Clin Pract Neurol"},{"key":"372_CR20","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12879-015-0787-1","volume":"15","author":"M Im\u00f6hl","year":"2015","unstructured":"Im\u00f6hl M, M\u00f6ller J, Reinert RR, Perniciaro S, van der Linden M, Aktas O. Pneumococcal meningitis and vaccine effects in the era of conjugate vaccination: results of 20 years of nationwide surveillance in Germany. BMC Infect Dis. 2015;15:61.","journal-title":"BMC Infect Dis"},{"key":"372_CR21","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1212\/WNL.0b013e31826e2684","volume":"79","author":"SG Heckenberg","year":"2012","unstructured":"Heckenberg SG, Brouwer MC, van der Ende A, van de Beek D. Adjunctive dexamethasone in adults with meningococcal meningitis. Neurology. 2012;79:1563\u20139.","journal-title":"Neurology"},{"key":"372_CR22","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jinf.2013.12.016","volume":"68","author":"BB Mook-Kanamori","year":"2014","unstructured":"Mook-Kanamori BB, Brouwer MC, Geldhoff M, van der Ende A, van de Beek D. Cerebrospinal fluid complement activation in patients with pneumococcal and meningococcal meningitis. J Infect. 2014;68:542\u20137.","journal-title":"J Infect"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-015-0372-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:08:37Z","timestamp":1589551717000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jneuroinflammation.com\/content\/12\/1\/149"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,8,15]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["372"],"URL":"https:\/\/doi.org\/10.1186\/s12974-015-0372-y","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,8,15]]},"article-number":"149"}}